×
About 47,645 results

ALLMedicine™ Escherichia Coli Center

Research & Reviews  16,550 results

Population pharmacokinetics of intramuscular recombinant Erwinia chrysanthemi asparagin...
https://doi.org/10.1111/cts.13499
Clinical and Translational Science; Lin T, Whigham T et. al.

Mar 18th, 2023 - JZP458 is a recombinant Erwinia chrysanthemi asparaginase for patients with acute lymphoblastic leukemia (ALL)/lymphoblastic lymphoma (LBL) who have developed hypersensitivity to Escherichia coli-derived asparaginases. A population pharmacokinetic...

GPR120 promotes neutrophil control of intestinal bacterial infection.
https://doi.org/10.1080/19490976.2023.2190311
Gut Microbes; Zhou Z, Yang W et. al.

Mar 18th, 2023 - G-protein coupled receptor 120 (GPR 120) has been implicated in anti-inflammatory functions. However, how GPR120 regulates the neutrophil function remains unknown. This study investigated the role of GPR120 in the regulation of neutrophil function...

Genome-wide identification of Kanamycin B binding RNA in Escherichia coli.
https://doi.org/10.1186/s12864-023-09234-3
BMC Genomics; Chang Y, Sun W et. al.

Mar 18th, 2023 - The aminoglycosides are established antibiotics that inhibit bacterial protein synthesis by binding to ribosomal RNA. Additional non-antibiotic aminoglycoside cellular functions have also been identified through aminoglycoside interactions with ce...

Experimental keratitis induced in rat by Acanthamoeba from distinct morphological group...
https://doi.org/10.1007/s00436-023-07817-3
Parasitology Research; de Souza Fernandes N, Caliari MV et. al.

Mar 17th, 2023 - Species of the genus Acanthamoeba are free-living protozoans that occasionally act as parasites, causing a severe, progressive corneal infection termed Acanthamoeba keratitis (AK). The variable pathogenic potential among Acanthamoeba lineages has ...

A swapped genetic code prevents viral infections and gene transfer.
https://doi.org/10.1038/s41586-023-05824-z
Nature Nyerges A, Vinke S et. al.

Mar 17th, 2023 - Engineering the genetic code of an organism has been proposed to provide a firewall from natural ecosystems by preventing viral infections and gene transfer1-6. However, numerous viruses and mobile genetic elements encode parts of the translationa...

see more →

Guidelines  4 results

Consumption of raw or unpasteurized milk and milk products by pregnant women and children.
https://doi.org/10.1542/peds.2013-3502
Pediatrics , et. al.

Dec 18th, 2013 - Sales of raw or unpasteurized milk and milk products are still legal in at least 30 states in the United States. Raw milk and milk products from cows, goats, and sheep continue to be a source of bacterial infections attributable to a number of vir...

Guideline for phenotypic screening and confirmation of carbapenemases in Enterobacteria...
https://doi.org/10.1016/j.ijantimicag.2010.05.014
International Journal of Antimicrobial Agents; Cohen Stuart J, Leverstein-Van Hall MA et. al.

Jul 6th, 2010 - Adequate detection of carbapenemase-producing Enterobacteriaceae is crucial for infection control measures and appropriate choice of antimicrobial therapy. This guideline aims to improve the detection of carbapenemase-producing Enterobacteriaceae ...

Recommendations for diagnosis of shiga toxin--producing Escherichia coli infections by ...
https://www.ncbi.nlm.nih.gov/pubmed/19834454
MMWR. Recommendations and Reports : Morbidity and Mortali... Gould LH, Bopp C et. al.

Oct 17th, 2009 - Shiga toxin--producing Escherichia coli (STEC) are a leading cause of bacterial enteric infections in the United States. Prompt, accurate diagnosis of STEC infection is important because appropriate treatment early in the course of infection might...

Guideline for the investigation and initial therapy of diarrhea-negative hemolytic urem...
https://doi.org/10.1007/s00467-008-0964-1
Pediatric Nephrology (Berlin, Germany); Ariceta G, Besbas N et. al.

Sep 19th, 2008 - This guideline for the investigation and initial treatment of atypical hemolytic uremic syndrome (HUS) is intended to offer an approach based on opinion, as evidence is lacking. It builds on the current ability to identify the etiology of specific...

see more →

Drugs  1,750 results see all →

Clinicaltrials.gov  222 results

Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in Post-kidney Transplantation Patients
https://clinicaltrials.gov/ct2/show/NCT02729116

Mar 8th, 2023 - A prospective randomized controlled trial of patients with a presumptive diagnosis of acute urinary tract infection caused by Extended Spectrum Beta Lactamase-producing Escherichia coli or Klebsiella pneumoniae in Post-kidney transplantation. Intr...

Effect of Imipenem and Meropenem on the Digestive Microbiota and the Emergence and Carriage of Multidrug-resistant Bacteria
https://clinicaltrials.gov/ct2/show/NCT05516433

Feb 27th, 2023 - Among enterobacteria, ESBL production is the leading cause of multidrug resistance. The first cases of ESBL-producing Enterobacteriaceae (EBLSE) infections were described in the 1980s and subsequently spread worldwide. Since the turn of the centur...

Εffectiveness of Intrauterine Antibiotic Administration for Treatment of Chronic Endometritis
https://clinicaltrials.gov/ct2/show/NCT05205993

Feb 24th, 2023 - An infectious endometrial environment caused by certain pathologies could compromise establishment of the initial interaction between the embryo and the endometrium. Chronic endometritis (CE) is a case of a persistent endometrial inflammation caus...

Microbiological Profile of VAP Patients in Respiratory ICU
https://clinicaltrials.gov/ct2/show/NCT05738928

Feb 22nd, 2023 - Ventilator-associated pneumonia (VAP) is one of the common serious infectious diseases encountered in the intensive care unit (ICU), which highly affects the healthcare cost and patient prognosis. All-cause of mortality associated with VAP has bee...

A Study of Three Different Doses of VAC52416 (ExPEC10V) in Adults Aged 60 to 85 Years in Stable Health
https://clinicaltrials.gov/ct2/show/NCT03819049

Feb 15th, 2023 - ExPEC10V (JNJ-69968054) is a 10-valent vaccine candidate in development for prevention of invasive extraintestinal pathogenic Escherichia coli (ExPEC) disease (IED) in adults 60 years of age and older. ExPEC10V consists of O-antigen polysaccharide...

see more →

News  515 results

Multidrug-Resistant Gram-Negative Infections Treatable With Newer Antibiotics, but Guidance Is Needed
https://www.medscape.com/viewarticle/985316

Dec 9th, 2022 - Multidrug-resistant gram-negative infections (MDRGNIs) are an emerging and deadly threat worldwide. Some of these infections are now resistant to nearly all antibiotics, and very few treatment options exist. Some of the remaining antibiotics for t...

New Doctors Find Joy and Frustration; Five Pathogens Cause Half of Bacterial Deaths; and Social Media and Youth Sexuality
https://www.medscape.com/viewarticle/984421

Nov 23rd, 2022 - New Doctors Find Fulfillment and Frustration New doctors say patient care is their biggest joy but add that they are frustrated by social factors. Some 27% of new doctors say that working with patients, helping people, and making the world a bette...

Most Global Bacterial Deaths in 2019 Linked to Five Pathogens
https://www.medscape.com/viewarticle/984426

Nov 21st, 2022 - In what may be the first estimate of bacterial deaths worldwide, researchers reported 33 bacterial pathogens were responsible for more than 1 in 7 deaths in 2019, with five pathogens linked to slightly more than half of those deaths. "Deaths assoc...

Emergency Med Case Challenge: Hemorrhoids, Urinary and Blood Infections in a Woman With Rigors
https://www.medscape.com/viewarticle/885566

Nov 14th, 2022 - Editor's Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills us...

Red Blood Cells Made to Deliver Antibiotics to Bacteria
https://www.medscape.com/viewarticle/983646

Nov 7th, 2022 - A red blood cell­–based platform delivered a potent antibiotic targeted to Escherichia coli in a preclinical trial. Over several years, “we developed experimental and computational techniques to study how proteins and drugs interact with membranes...

see more →

Patient Education  17 results see all →